Key Managment

Dr. Madhavan Nallani, Founder and CEO.
Developed the core intellectual property of the company while working in Germany, the Netherlands and Singapore (at the Institute of Materials Research & Engineering and also at Nanyang Technological University).
Dr. Peter Moran, COO.
Previously co-founded Singular ID, a successful Singapore technology company which was acquired by one of the world’s largest pharmaceutical packaging companies.

Dr. Erich Erber, Director

Founder the Erber Group, an Austrian animal nutrition company, which consists of more than 50 affiliates in all continents.  Recipient of numerous awards including the Austrian Export award and Ernst & Young Entrepreneur of the Year and is an Honorary Senator of the University of Veterinary Medicine and the University of Natural Resources and Applied Life Sciences, Vienna.

Erich is the key investor representative on ACM Biolabs' Board of Directors.

Key Technical Staff

Dr. Fabien Décaillot
PhD, Université Louis Pasteur de Strasbourg in France. He did postdoctoral research at Mount Sinai School of Medicine and Rockefeller University both in the USA. He then joined the Antibody Discovery platform of Singapore Immunology Network (SIgN/ A*Star).
Dr. Tom Cornell
PhD, King’s College London, UK. He did postdoctoral research at Nanyang Technological University, Singapore.

Dr. Su Xingfang
PhD, Massachusetts Institute of Technology (MIT), USA. On T-Up secondment from the Institute of Materials Engineering (IMRE), Singapore.

Dr. Chiara Ardiccioni
PhD, Sapienza University of Rome, Italy. She did postdoctoral research at Columbia University, USA.

Dr. Kelvin Yong
PhD, in Biochemistry from University of Melbourne, Australia. His specialty is membrane proteins including difficult targets such as GPCRs.